ESTRO 2024 - Abstract Book

S234

Brachytherapy - Gynaecology

ESTRO 2024

Conclusion:

The median RV-RP doses were well within the dose constraint <65Gy in this cohort which had no optimisation for RV-RP. The ability to use interstitial technique reduced the RV-RP dose significantly and none of this patient cohort breached the dose constraint. There was no correlation between the RV-RP and vaginal toxicity, although we note that in our patient cohort, the toxicities grade ≥2 were lower than published series, perhaps reflecting the multiple confounding factors that contribute to vaginal toxicity.

Keywords: RV-RP, cervix

556

Digital Poster

LACC not candidates for brachytherapy: a Spanish survey (on behalf of GINECOR/SEOR)

Silvia Rodríguez Villalba 1 , Sofia Cordoba Largo 2 , Javier Anchuelo Latorre 3 , Jose Antonio Domínguez Rullan 4 , Arantxa Campos Bonel 5 , María Ana Estornell Gualde 6 , Elena García Morales 7 , Diana Guevara García 1 , Javier Luna Tirado 8 , Ana Laura Rivero Pérez 3 , Susana Roldán Ortega 6 , Noelia Sanmamed Salgado 9 , Salvador José Segado Muñoz 10 , Maider Sierra Marín 11 , Ignacio Zapardiel 12 1 Hospital Clínica Benidorm, Radiotherapy Department, Benidorm, Spain. 2 Hospital Universitario Puerta de Hierro, Radiotherapy Department, Madrid, Spain. 3 Hospital Universitario Marques de Valdecilla, Radiotherapy Department, Santander, Spain. 4 Hospital Universitario Ramón y Cajal, Radiotherapy Department, Madrid, Spain. 5 Hospital Universitario Miguel Servet, Radiotherapy Department, Zaragoza, Spain. 6 Hospital Universitario y Politécnico La Fe, Radiotherapy Department, Valencia, Spain. 7 Hospital Universitario Nuestra Señora de la Candelaria, Radiotherapy Department, Tenerife, Spain. 8 Hospital Universitario Fundación Jiménez Díaz,